Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global antifungal drugs market size reached US$ 14.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2027, exhibiting a growth rate (CAGR) of 3.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.

Antifungal Drugs Market Trends:

The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class and indication.

Breakup by Drug Class:

  • Azoles
    • Voriconazole (Vfend)
    • Posaconazole (Noxafil)
    • Clotrimazole (Canesten)
    • Isavuconazole (CRESEMBA)
    • Others
  • Echinocandins
    • Caspofungin (Cancidas)
    • Micafungin (Mycamine/ Funguard)
    • Others
  • Polyenes
    • Amphotericin (AmBisome)
    • Others
  • Allylamines
    • Terbinafine (Lamisil)
    • Others
  • Others
     

Breakup by Indication:

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
    • Invasive Candidiasis
    • Vulvovaginal Candidiasis (VVC)
    • Mouth/Throat/Esophageal Candidiasis
    • Others
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Drug Class, Indication, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Antifungal Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Azoles
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Voriconazole (Vfend)
           6.1.2.2 Posaconazole (Noxafil)
           6.1.2.3 Clotrimazole (Canesten)
           6.1.2.4 Isavuconazole (CRESEMBA)
           6.1.2.5 Others
        6.1.3 Market Forecast
    6.2    Echinocandins
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Caspofungin (Cancidas)
           6.2.2.2 Micafungin (Mycamine/ Funguard)
           6.2.2.3 Others
        6.2.3 Market Forecast
    6.3    Polyenes
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Amphotericin (AmBisome)
           6.3.2.2 Others
        6.3.3 Market Forecast
    6.4    Allylamines
        6.4.1 Market Trends
        6.4.2 Key Segments
           6.4.2.1 Terbinafine (Lamisil)
           6.4.2.2 Others
        6.4.3 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Indication
    7.1    Dermatophytosis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Aspergillosis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Candidiasis
        7.3.1 Market Trends
        7.3.2 Key Segments
           7.3.2.1 Invasive Candidiasis
           7.3.2.2 Vulvovaginal Candidiasis (VVC)
           7.3.2.3 Mouth/Throat/Esophageal Candidiasis
           7.3.2.4 Others
        7.3.3 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Arcadia Consumer Healthcare Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Astellas Pharma Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bayer AG
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    GlaxoSmithKline Plc
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Merck & Co. Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Merck KGaA
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Novartis AG
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Pfizer Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Sanofi S.A.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Scynexis Inc.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials

List of Figures

Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2021
Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2021
Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2021
Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Antifungal Drugs Market: Competitive Structure
Table 6: Global: Antifungal Drugs Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global antifungal drugs market was valued at US$ 14.0 Billion in 2021.

 

We expect the global antifungal drugs market to exhibit a CAGR of 3.7% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic has led to the escalating adoption of antifungal drugs to treat infectious disease, such as mucormycosis among the coronavirus-infected patients.

The rising prevalence of fungal and nosocomial infections, along with the increasing availability of OTC antifungal capsule, gel, liquid, and pill variants or intravenous solutions, which are injected directly into the bloodstream to minimize and prevent fungal infection, is primarily driving the global antifungal drugs market.

Based on the drug class, the global antifungal drugs market has been segregated into azoles, echinocandins, polyenes, allylamines, and others. Among these, azoles currently hold the largest market share.

Based on the indication, the global antifungal drugs market can be bifurcated into dermatophytosis, aspergillosis, candidiasis, and others. Currently, candidiasis exhibits a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global antifungal drugs market include Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., and Scynexis Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4